JAMES PALEN: Open Payments
NPI 1598902728 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,541 in 88 payments from 26 companies in 2025. Trend: 2023 $1,717 · 2024 $1,569 · 2025 $1,541
Food & beverage: $1,541
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $293 |
| Otsuka America Pharmaceutical, Inc. | 9 | $187 |
| AstraZeneca Pharmaceuticals LP | 9 | $174 |
| Lundbeck LLC | 5 | $82 |
| Lilly USA, LLC | 4 | $66 |
| Exact Sciences Corporation | 4 | $66 |
| Viatris Specialty LLC | 4 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| Verona Pharma, Inc. | 3 | $53 |
| Novo Nordisk Inc | 3 | $50 |
Products named: REXULTI, VRAYLAR, BREZTRI, YUPELRI, FANAPT, Ohtuvayre, MOUNJARO, Cologuard Collection Kit.
Industry payments across MO — which companies pay providers there.
